Loading: 100%
EXELIXIS, INC. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 287 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker EXELno data available
Financial year endsFY ends End of Januaryno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,07,515,022,530,0
datesClosing price (adj.)
13.10.201724.76
11.10.201725.65
04.10.201725.26
27.09.201723.75
20.09.201728.27
13.09.201727.11
06.09.201728.17
30.08.201728.28
23.08.201726.79
16.08.201726.78
09.08.201727.19
02.08.201726.63
26.07.201728.02
19.07.201726.75
12.07.201726.61
05.07.201724.97
27.06.201723.59
20.06.201722.28
13.06.201719.90
06.06.201719.13
30.05.201718.32
23.05.201719.80
16.05.201721.56
09.05.201721.84
02.05.201723.16
25.04.201722.08
18.04.201720.88
11.04.201720.96
04.04.201721.25
28.03.201721.28
21.03.201720.44
14.03.201721.74
07.03.201722.24
28.02.201721.53
21.02.201723.11
14.02.201722.02
07.02.201720.57
31.01.201718.12
24.01.201718.53
17.01.201717.79
10.01.201718.91
03.01.201714.73
27.12.201615.70
19.12.201616.29
12.12.201616.44
05.12.201617.83
28.11.201616.49
21.11.201617.17
14.11.201616.76
07.11.201612.36
31.10.201610.59
24.10.201611.29
17.10.201611.51
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
24.76n/a
Market Capitalisation
in million USD
7,243n/a
Enterprise Value
in million USD
7,458n/a
Common Shares Outstanding
as per Apr 24, 2017
292,512,348n/a
Preferred Shares Outstanding
as per Apr 24, 2017
n/a
Average Basic Shares Outstanding
TTM
266,172,500n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Exelixis Inc is a part of the healthcare sector. As a biotechnology company, it develops small molecule therapies for the treatment of cancer.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 167n/a
Receivables 0n/a
Total Current Assets 179n/a
PP&E 1n/a
Total Assets 332n/a
Accounts Payable 6n/a
Current Debt 0n/a
Total Current Liabilities 52n/a
Long-Term Debt 383n/a
Total Liabilities 437n/a
Total Equity -104n/a
Cash Flow
Depreciation & Amortisation 1n/a
Change in Working Capital -26n/a
Operating Cash Flow -142n/a
Net Change in PP&E and Intangibles 1n/a
Investing Cash Flow 50n/a
Dividends Paid 0n/a
Financing Cash Flow 153n/a
Total Change in Cash 61n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value -0.01n/a
Other Ratios
Current Ratio 341.9%n/a
Liabilities to Equity Ratio -418.6%n/a
Debt to Assets Ratio 115.2%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
147
185
290
47
47
31
25
37
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
-1
-2
-4
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
147
185
290
47
47
30
23
33
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-269
-244
-190
-161
-161
-230
-240
-154
Selling, General & Administrative
-34
-33
-33
-32
-32
-51
-51
-57
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-235
-211
-157
-129
-129
-179
-189
-96
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
-122
-59
100
-113
-113
-200
-217
-120
Non-Operating Income (Loss)
14
9
18
29
29
47
53
49
Interest Expense, net
13
9
16
27
27
45
49
49
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
2
0
1
2
2
1
4
0
Pretax Income (Loss), Adjusted
-108
-49
117
-84
-84
-153
-164
-71
Abnormal Gains (Losses)
157
-41
-12
-9
-9
-1
-8
-1
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
50
-90
105
-93
-93
-154
-172
-72
Income Tax (Expense) Benefit, net
1
0
-1
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
51
-90
104
-93
-93
-154
-171
-72
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
51
-90
104
-93
-93
-154
-171
-72
Minority Interest
0
0
0
0
0
0
0
0
Net Income
51
-90
104
-93
-93
-154
-171
-72
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
51
-90
104
-93
-93
-154
-171
-72
Remarks
restated on Feb 22, 2012 n/a
calculated values,
restated on Feb 21, 2013 n/a
calculated values,
restated on Feb 20, 2014 n/a
calculated values,
restated on Feb 20, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
163
194
411
242
242
167
167
Cash & Cash Equivalents
n/a
97
74
170
104
104
142
142
Short Term Investments
n/a
65
120
241
138
138
25
25
Accounts & Notes Receivable
n/a
6
30
3
4
4
5
5
Accounts Receivable, Net
n/a
0
0
0
0
0
0
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
0
0
0
3
3
3
3
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
15
4
18
17
17
4
4
Prepaid Expenses
n/a
15
4
6
5
5
4
4
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
12
12
12
0
0
Total Current Assets
n/a
183
229
433
267
267
179
179
Property, Plant & Equipment, Net
n/a
16
9
6
5
5
1
1
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
87
85
182
144
144
84
84
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
74
71
100
87
87
69
69
Intangible Assets
n/a
0
0
0
0
0
0
0
Goodwill
n/a
64
64
64
64
64
64
64
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
10
7
37
24
24
5
5
Total Noncurrent Assets
n/a
177
164
289
237
237
154
154
Total Assets
n/a
361
393
721
503
503
332
332
Liabilities and owners' equity
Payables & Accruals
n/a
55 54602000
41 41052000
47 47128000
70 70216000
70 70216000
52 52251000
49 49046000
Accounts Payable
n/a
2 2046000
2 1957000
4 4398000
9 9345000
9 9345000
6 6401000
6 6401000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
53 52556000
39 39095000
43 42730000
61 60871000
61 60871000
46 45850000
43 42645000
Short Term Debt
n/a
38 37748000
5 4870000
13 13170000
12 11762000
12 11762000
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
108 107591000
46 46403000
21 21406000
6 5875000
6 5875000
0 0
3 3205000
Deferred Revenue
n/a
100 100297000
42 41920000
16 16321000
1 1450000
1 1450000
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
7 7294000
4 4483000
5 5085000
4 4425000
4 4425000
0 0
3 3205000
Total Current Liabilities
n/a
200 199941000
92 92325000
82 81704000
88 87853000
88 87853000
52 52251000
52 52251000
Long Term Debt
n/a
178 177697000
186 186140000
337 336703000
345 344522000
345 344522000
381 381435000
383 382820000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
211 211477000
24 24165000
6 6256000
5 4674000
5 4674000
3 2960000
2 1575000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
202 202472000
16 16321000
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
9 9005000
8 7844000
6 6256000
5 4674000
5 4674000
3 2960000
2 1575000
Total Noncurrent Liabilities
n/a
389 389174000
210 210305000
343 342959000
349 349196000
349 349196000
384 384395000
384 384395000
Total Liabilities
n/a
589 589115000
303 302630000
425 424663000
437 437049000
437 437049000
437 436646000
437 436646000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
954 953717000
1,197 1197127000
1,551 1550528000
1,565 1564854000
1,565 1564854000
1,833 1832969000
1,833 1832969000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-1,182 -1182054000
-1,106 -1106357000
-1,254 -1254002000
-1,499 -1498762000
-1,499 -1498762000
-1,937 -1937041000
-1,937 -1937041000
Other Equity
n/a
0 12000
0 -138000
0 -92000
0 146000
0 146000
0 -232000
0 -232000
Equity Before Minority Interest
n/a
-228 -228325000
91 90632000
296 296434000
66 66238000
66 66238000
-104 -104304000
-104 -104304000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
-228 -228325000
91 90632000
296 296434000
66 66238000
66 66238000
-104 -104304000
-104 -104304000
Total Liabilities & Equity
n/a
361 360790000
393 393262000
721 721097000
503 503287000
503 503287000
332 332342000
332 332342000
Remarks restated on n/a restated on Feb 22, 2012 n/a restated on Feb 21, 2013 n/a restated on Feb 20, 2014 n/a restated on Feb 20, 2014 n/a restated on Mar 2, 2015 n/a restated on Feb 27, 2017 n/a restated on May 1, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-140
-92
76
-148
-148
-245
-269
-170
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
13
11
7
6
6
3
2
1
Non-Cash Items
32
23
23
27
28
45
41
53
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
80
-42
-265
-9
-9
-2
-10
-26
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
-15
-101
-159
-123
-123
-199
-235
-142
Change in Fixed Assets & Intangibles
-6
-2
1
-1
-1
-2
0
1
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-111
-27
-57
-223
-223
135
133
35
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
2
9
3
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
2
0
2
-36
-36
11
13
14
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-112
-20
-51
-259
-259
144
146
50
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-38
125
-6
273
273
-13
-12
-4
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
4
6
194
206
206
2
77
157
Increase in Capital Stock
4
6
194
206
206
2
77
157
Decrease in Capital Stock
0
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
-34
131
188
478
478
-12
65
153
Net Cash Before Disc. Operations and FX
-161
11
-23
96
96
-66
-24
61
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
-161
11
-23
96
96
-66
-24
61
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
Net Changes in Cash
-161
11
-23
96
96
-66
-24
61
Remarks
restated on Feb 22, 2012 n/a
calculated values,
restated on Feb 21, 2013 n/a
calculated values,
restated on Feb 20, 2014 n/a
calculated values,
restated on Feb 20, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo